Genelux (GNLX) News Today → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free GNLX Stock Alerts $3.61 -0.22 (-5.74%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13 at 3:34 PM | marketbeat.comGenelux's (GNLX) "Buy" Rating Reiterated at HC WainwrightHC Wainwright restated a "buy" rating and set a $32.00 price objective on shares of Genelux in a research report on Monday.May 11 at 5:41 PM | markets.businessinsider.comBuy Rating Affirmed for Genelux Corp on Strong Trial Progress and Solid FinancialsMay 10 at 11:37 AM | insidertrades.comInsider Selling: Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells 6,025 Shares of StockMay 10 at 1:03 AM | investorplace.comGNLX Stock Earnings: Genelux Misses EPS for Q1 2024May 9, 2024 | marketbeat.comAladar Szalay Sells 6,025 Shares of Genelux Co. (NASDAQ:GNLX) StockGenelux Co. (NASDAQ:GNLX - Get Free Report) major shareholder Aladar Szalay sold 6,025 shares of the firm's stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $3.67, for a total transaction of $22,111.75. Following the completion of the sale, the insider now owns 1,189,706 shares in the company, valued at $4,366,221.02. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Major shareholders that own more than 10% of a company's stock are required to disclose their sales and purchases with the SEC.May 9, 2024 | globenewswire.comGenelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business UpdatesMay 5, 2024 | finance.yahoo.comGenelux Corporation's (NASDAQ:GNLX) market cap rose US$11m last week; individual investors who hold 54% profited and so did insidersMay 3, 2024 | americanbankingnews.comAladar Szalay Sells 6,403 Shares of Genelux Co. (NASDAQ:GNLX) StockMay 3, 2024 | americanbankingnews.comAladar Szalay Sells 33,061 Shares of Genelux Co. (NASDAQ:GNLX) StockMay 2, 2024 | insidertrades.comGenelux Co. (NASDAQ:GNLX) Major Shareholder Sells $20,809.75 in StockMay 2, 2024 | insidertrades.comInsider Selling: Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells 33,061 Shares of StockApril 25, 2024 | insidertrades.comInsider Selling: Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells 8,064 Shares of StockApril 20, 2024 | investing.comGenelux Corp insider sells shares worth over $250kApril 19, 2024 | insidertrades.comGenelux Co. (NASDAQ:GNLX) Major Shareholder Aladar Szalay Sells 48,683 SharesApril 17, 2024 | msn.comGenelux (GNLX) Price Target Decreased by 22.96% to 26.52April 14, 2024 | marketbeat.comVanguard Group Inc. Buys 925,258 Shares of Genelux Co. (NASDAQ:GNLX)Vanguard Group Inc. boosted its stake in shares of Genelux Co. (NASDAQ:GNLX - Free Report) by 1,660.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 980,993 shares of the company's stock after buyinApril 4, 2024 | marketbeat.comResearch Analysts Set Expectations for Genelux Co.'s Q1 2024 Earnings (NASDAQ:GNLX)Genelux Co. (NASDAQ:GNLX - Free Report) - Research analysts at HC Wainwright issued their Q1 2024 earnings estimates for shares of Genelux in a note issued to investors on Tuesday, April 2nd. HC Wainwright analyst E. Bodnar expects that the company will post earnings per share of ($0.26) for theApril 3, 2024 | marketbeat.comGenelux's (GNLX) "Speculative Buy" Rating Reiterated at BenchmarkBenchmark restated a "speculative buy" rating and set a $30.00 price objective on shares of Genelux in a research report on Wednesday.April 3, 2024 | marketbeat.comBrokers Set Expectations for Genelux Co.'s FY2028 Earnings (NASDAQ:GNLX)Genelux Co. (NASDAQ:GNLX - Free Report) - Research analysts at HC Wainwright issued their FY2028 EPS estimates for shares of Genelux in a research report issued to clients and investors on Tuesday, April 2nd. HC Wainwright analyst E. Bodnar expects that the company will earn $0.82 per share for tApril 2, 2024 | marketbeat.comHC Wainwright Lowers Genelux (NASDAQ:GNLX) Price Target to $32.00HC Wainwright cut their price objective on Genelux from $35.00 to $32.00 and set a "buy" rating on the stock in a research report on Tuesday.April 2, 2024 | investorplace.comGNLX Stock Earnings: Genelux Misses EPS for Q4 2023April 1, 2024 | globenewswire.comGenelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateMarch 19, 2024 | seekingalpha.comAtossa climbs after cancer therapy updateMarch 15, 2024 | msn.comTD Cowen cuts Immuneering to market perform, cites Phase 1 dataMarch 15, 2024 | marketbeat.comShort Interest in Genelux Co. (NASDAQ:GNLX) Expands By 30.3%Genelux Co. (NASDAQ:GNLX - Get Free Report) was the target of a significant increase in short interest in the month of February. As of February 29th, there was short interest totalling 1,590,000 shares, an increase of 30.3% from the February 14th total of 1,220,000 shares. Currently, 8.1% of the company's stock are short sold. Based on an average daily volume of 125,100 shares, the days-to-cover ratio is presently 12.7 days.March 10, 2024 | msn.comCytomX FY 2023 Earnings PreviewMarch 5, 2024 | marketbeat.comShort Interest in Genelux Co. (NASDAQ:GNLX) Rises By 9.9%Genelux Co. (NASDAQ:GNLX - Get Free Report) was the target of a large increase in short interest in the month of February. As of February 15th, there was short interest totalling 1,220,000 shares, an increase of 9.9% from the January 31st total of 1,110,000 shares. Currently, 6.2% of the company's shares are short sold. Based on an average trading volume of 132,200 shares, the short-interest ratio is presently 9.2 days.February 23, 2024 | benzinga.comGenelux Stock (NASDAQ:GNLX) Insider TradesFebruary 12, 2024 | msn.comG1 Therapeutics stock dives 36% post-market on P3 study updateFebruary 6, 2024 | msn.comGenelux Corp. Unveils Future-Oriented Corporate PresentationFebruary 3, 2024 | msn.comGenelux Corp. Estimates $23.2 Million in Year-End AssetsJanuary 23, 2024 | finance.yahoo.comHealthcare IT Leaders Adds Health Industry Veteran Mary Mirabelli to Board of DirectorsJanuary 2, 2024 | marketbeat.comShort Interest in Genelux Co. (NASDAQ:GNLX) Rises By 11.1%Genelux Co. (NASDAQ:GNLX - Get Free Report) was the target of a large growth in short interest in December. As of December 15th, there was short interest totalling 889,700 shares, a growth of 11.1% from the November 30th total of 801,000 shares. Based on an average daily volume of 143,900 shares, the short-interest ratio is currently 6.2 days. Currently, 4.5% of the company's stock are sold short.December 24, 2023 | marketbeat.comAE Wealth Management LLC Has $4.77 Million Stock Position in Genelux Co. (NASDAQ:GNLX)AE Wealth Management LLC lifted its position in shares of Genelux Co. (NASDAQ:GNLX - Free Report) by 1,370.0% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 194,875 shares of the company's stock after buying an additional 181,618 sharesDecember 21, 2023 | benzinga.comGenelux Stock (NASDAQ:GNLX) Dividends: History, Yield and DatesDecember 15, 2023 | finance.yahoo.comInsider Sell Alert: Director James Tyree Offloads 9,000 Shares of Genelux Corp (GNLX)December 14, 2023 | marketbeat.comGenelux Co. (NASDAQ:GNLX) Director John Thomas Sells 9,000 SharesGenelux Co. (NASDAQ:GNLX - Get Free Report) Director John Thomas sold 9,000 shares of the business's stock in a transaction that occurred on Wednesday, December 13th. The stock was sold at an average price of $13.38, for a total value of $120,420.00. Following the sale, the director now owns 463,460 shares of the company's stock, valued at approximately $6,201,094.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.November 27, 2023 | msn.comHC Wainwright & Co. Initiates Coverage of Genelux (GNLX) with Buy RecommendationNovember 27, 2023 | msn.comGenelux gets fast track status for Olvi-Vec in ovarian cancerNovember 27, 2023 | msn.comHC Wainwright starts Genelux at buy, cites Olvi-Vec potentialNovember 27, 2023 | markets.businessinsider.comGenelux Says FDA Grants Fast Track Designation For Olvi-Vec To Treat Ovarian CancerNovember 27, 2023 | finance.yahoo.comGenelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian CancerNovember 23, 2023 | benzinga.comGenelux VP Sold $191K In Company StockNovember 17, 2023 | finance.yahoo.comGenelux Corporation (NASDAQ:GNLX) most popular amongst retail investors who own 57%, insiders hold 25%November 15, 2023 | msn.comGenelux GAAP EPS of -$0.20 misses by $0.02November 14, 2023 | finance.yahoo.comGenelux Corporation Reports Third Quarter 2023 Financial Results and Provides General Business UpdatesOctober 31, 2023 | morningstar.comGenelux Corp GNLXOctober 27, 2023 | msn.comGenelux 10% owner Aladar Szalay discloses sale of 5,704 sharesOctober 27, 2023 | benzinga.com10% Owner of Genelux Makes $110K SaleOctober 26, 2023 | msn.comGenelux Corporation 10% owner discloses sale of 49,987 shares Get Genelux News Delivered to You Automatically Sign up to receive the latest news and ratings for GNLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Exposed: 10 CENT Crypto to Explode May 20th? (Ad)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career… Click For My #1 FREE Crypto for 2024 GNLX Media Mentions By Week GNLX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNLX News Sentiment▼0.350.58▲Average Medical News Sentiment GNLX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNLX Articles This Week▼81▲GNLX Articles Average Week Get Genelux News Delivered to You Automatically Sign up to receive the latest news and ratings for GNLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IO Biotech News Assertio News Cue Biopharma News BeyondSpring News Adagene News Allakos News Citius Pharmaceuticals News Oramed Pharmaceuticals News Clearside Biomedical News Eton Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GNLX) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genelux Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
